HOME › Press Releases › Ablation Technologies Market worth $4.44 Billion USD by 2020
Ablation Technologies Market worth $4.44 Billion USD by 2020
The report “Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) & Application (Cardiovascular, Cancer, Pain Management, Cosmetic Surgery, Ophthalmology, Gynecology) - Global Forecasts to 2020”, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
Browse 73 market data Tables and 40 Figures spread through 168 Pages and in-depth TOC on "Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) & Application (Cardiovascular, Cancer, Pain Management, Cosmetic Surgery, Ophthalmology, Gynecology) - Global Forecasts to 2020"
Early buyers will receive 10% customization on reports.
This report studies the global ablation technologies market over the forecast period of 2015 to 2020. The market is expected to reach $4.44 Billion by 2020, at CAGR of 10.5% from 2015 to 2020.
Based on type of product, the global ablation technologies market is classified into seven major segments, namely, light/laser ablators, radiofrequency ablators, electrical ablators, ultrasound ablators, microwave ablators, cryoablation devices, and hydrothermal ablators. The light/laser ablators segment is further classified into excimer laser ablators and cold laser ablators. The radiofrequency ablators market is categorized into temperature-controlled RF ablators, fluid-cooled RF ablators, and robotic catheter manipulation systems. Likewise, the electrical ablators market is categorized into argon plasma/beam coagulators, and irreversible electroporation ablators. The ultrasound ablators segment includes high-intensity focused ultrasound ablators, magnetic resonance guided focused ultrasound ablators, ultrasonic surgical ablation systems, and extracorporeal shockwave lithotripsy systems. Similarly, the cryoablation devices segment is categorized into three sub-segments, namely tissue contact probe ablators, tissue spray probe ablators, and epidermal and subcutaneous cryoablation systems.
On the basis of applications, the global ablation technologies market is divided into nine segments, namely, cancer treatment, cardiovascular disease treatment, ophthalmological treatment, gynecological treatment, urological treatment, orthopedic treatment, cosmetic surgical applications, pain management, and others (fecal incontinence, psoriasis, tonsillectomy, port wine stains, and gastro-esophageal reflex disease).
A number of factors such as increasing number of ablation procedures, rising incidence of cancer, growing prevalence of cardiovascular diseases, emergence of next-generation ablation products and technologies growing adoption of minimally invasive procedures, increasing number of hospitals, surgical, and ablation centers and improving reimbursement scenario in established markets are driving the growth of the global ablation technologies market. On the other hand, factors such as reuse and reprocessing of devices in developing countries, Healthcare cost-containment measures are restricting the growth of the global ablation technologies market.
As of 2015, North America holds the largest share of the global ablation technologies market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2015 to 2020. A number of factors, including growing popularity of minimally invasive surgeries, government efforts to increase population access for elective surgeries, rising focus of global players, large population base and improving healthcare infrastructure are stimulating the growth of the ablation technologies market in the Asia-Pacific region.
Medtronic, Inc. (U.S.), Biosense Webster, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), CONMED Corporation (U.S.), AngioDynamics, Inc. (U.S.), AtriCure, Inc. (U.S.), Smith & Nephew plc (U.K.), and Olympus Corporation (Japan) are the major players in the global ablation technologies market.
MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India